Binding of MUC1-sT to Siglec-9 on macrophages induces a tumor-associated macrophage (TAM) phenotype, that inhibits CD8+ T cell proliferation and results in the upregulation of IDO, CD163 and PD-L1 in-vivo (113, 114). Here, CD8A is linked to neoplasm.